Skip to main content

Immunopathogenesis of Extrahepatic Manifestations in HAV, HBV, and HCV Infections

Importance of Recognition and Therapy

  • Chapter
Liver Immunology

Abstract

Hepatitis A, B, and C virus (HAV, HBV, and HCV) infections can be associated with various extrahepatic manifestations, which can be seen in both acute and chronic infections. Extrahepatic manifestations in acute hepatitis are often seen in hepatitis B, less often in hepatitis C, and only occasionally in hepatitis A. Clinically important extrahepatic manifestations are most often seen in chronic hepatitis C infection. Therefore some of the causative pathomechanisms are explained in more detail for HCV, e.g., the autoimmune syndromes and cryoglobulinemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beyazit Y, Guven GS, Kekilli M, Koklu S, Yolcu OF, Shorbagi A. Acute pericarditis and renal failure complicating acute hepatitis A infection. South Med J 2006; 99: 82–84.

    Article  PubMed  Google Scholar 

  2. Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992; 10(Suppl 1):S18–20.

    Article  PubMed  Google Scholar 

  3. Eng C, Chopra S. Acute renal failure in nonfulminant hepatitis A. J Clin Gastroenterol 1990; 12:717–718.

    Article  PubMed  CAS  Google Scholar 

  4. Chio F Jr, Bakir AA. Acute renal failure in hepatitis A. Int J Artif Organs 1992; 15:413–416.

    PubMed  Google Scholar 

  5. Geltner D, Naot Y, Zimhoni O, Gorbach S, Bar-Khayim Y. Acute oliguric renal failure complicating type A nonfulminant viral hepatitis. A case presentation and review of the literature. J Clin Gastroenterol 1992; 14:160–162.

    Article  PubMed  CAS  Google Scholar 

  6. Nachbaur K, Konig P, Rumpelt HJ, Schobel B, Lhotta K, Vogel W. Acute renal failure complicating non-fulminant hepatitis A. Clin Nephrol 1996; 45:398–400.

    PubMed  CAS  Google Scholar 

  7. Cacoub P, Saadoun D, Bourliere M, et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 2005; 43:764–770.

    Article  PubMed  CAS  Google Scholar 

  8. Duffy J, Lidsky MD, Sharp JT, et al Polyarthritis, polyarteritis and hepatitis B. Medicine (Balt) 1976; 55:19–37.

    Article  CAS  Google Scholar 

  9. Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 2004; 8:403–418.

    Article  PubMed  Google Scholar 

  10. Alpert E, Isselbacher KJ, Schur PH. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med 1971; 285:185–189.

    Article  PubMed  CAS  Google Scholar 

  11. Wands JR, Alpert E, Isselbacher KJ. Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes. Gastroenterology 1975; 69:1286–1291.

    PubMed  CAS  Google Scholar 

  12. Drueke T, Barbanel C, Jungers P, et al. Hepatitis B antigen-associated periarteritis nodosa in patients undergoing long-term hemodialysis. Am J Med 1980; 68:86–90.

    Article  PubMed  CAS  Google Scholar 

  13. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002; 97:2402–2407.

    Article  PubMed  Google Scholar 

  14. Chan G, Kowdley KV. Extrahepatic manifestations of chronic viral hepatitis. Compr Ther 1995; 21:200–205.

    PubMed  CAS  Google Scholar 

  15. Guillevin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Balt) 1995; 74:238–253.

    Article  CAS  Google Scholar 

  16. Guillevin L, Visser H, Noel LH, et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome—62 patients. J Rheumatol 1993; 20:1345–1349.

    PubMed  CAS  Google Scholar 

  17. Fye KH, Becker MJ, Theofilopoulos AN, Moutsopoulos H, Feldman JL, Talal N. Immune complexes in hepatitis B antigenassociated periarteritis nodosa. Detection by antibody-dependent cell-mediated cytotoxicity and the Raji cell assay. Am J Med 1977; 62:783–791.

    Article  PubMed  CAS  Google Scholar 

  18. Rogers RB, Smith JG Jr, Chalker DK. Hepatitis and the skin. J Am Acad Dermatol 1982; 7:552–554.

    PubMed  CAS  Google Scholar 

  19. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001; 16:269–274.

    Article  PubMed  CAS  Google Scholar 

  20. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004; 24:198–211.

    Article  PubMed  CAS  Google Scholar 

  21. McElgunn PS. Dermatologic manifestations of hepatitis B virus infection. J Am Acad Dermatol 1983; 8:539–548.

    PubMed  CAS  Google Scholar 

  22. Katakura Y, Yotsuyanagi H, Hashizume K, et al. Pancreatic involvement in chronic viral hepatitis. World J Gastroenterol 2005; 11:3508–3513.

    PubMed  CAS  Google Scholar 

  23. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitisassociated aplastic anemia. N Engl J Med 1997; 336:1059–1064.

    Article  PubMed  CAS  Google Scholar 

  24. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Balt) 2000; 79:47–56.

    Article  CAS  Google Scholar 

  25. Bandi L. Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent— and thus overlooked. Postgrad Med 2003; 113:73–76, 86.

    PubMed  Google Scholar 

  26. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328:465–470.

    Article  PubMed  CAS  Google Scholar 

  27. Clifford BD, Donahue D, Smith S, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 231:613–619.

    Google Scholar 

  28. Rasul I, Shepherd FA, Kamel-Reid S, Krajden M, Pantalony D, Heathcote EJ. Detection of occult low-grade b-cell non-Hodgkin’s lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 1999; 29:543–547.

    Article  PubMed  CAS  Google Scholar 

  29. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125:1723–1732.

    Article  PubMed  Google Scholar 

  30. Moorman J, Saad M, Kosseifi S, Krishnaswamy G. Hepatitis C virus and the lung: implications for therapy. Chest 2005; 128: 2882–2892.

    Article  PubMed  Google Scholar 

  31. Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep 2004; 4: 194–198.

    Article  PubMed  Google Scholar 

  32. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24:38–47.

    Article  PubMed  CAS  Google Scholar 

  33. Simsek H, Telatar H. Successful treatment of hepatitis B virusassociated polyarteritis nodosa by interferon alpha alone. J Clin Gastroenterol 1995; 20:263–265.

    Article  PubMed  CAS  Google Scholar 

  34. Guillevin L, Lhote F, Sauvaget F, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994; 53:334–337.

    PubMed  CAS  Google Scholar 

  35. Czaja AJ, Kruger M, Santrach PJ, Breanndan Moore S, Manns MP. Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am. J. Gastroenterol. 1997; 92:2197–2200.

    PubMed  CAS  Google Scholar 

  36. Gan SI, Devlin SM, Scott-Douglas NW, Burak KW. Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis B infection. Can J Gastroenterol 2005; 19:625–629.

    PubMed  CAS  Google Scholar 

  37. Durand JM, Cacoub P, Lunel-Fabiani F, et al. Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol 1998; 25:1115–1117.

    PubMed  CAS  Google Scholar 

  38. Kim JD, Sherker AH. Antiviral therapy: role in the management of extrahepatic diseases. Gastroenterol Clin North Am 2004; 33: 693–708, xi.

    Article  PubMed  Google Scholar 

  39. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347:89–94.

    Article  PubMed  CAS  Google Scholar 

  40. Alric L, Plaisier E, Thebault S, et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004; 43:617–623.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Pischke, S., Vogel, A., Jaeckel, E., Manns, M.P. (2007). Immunopathogenesis of Extrahepatic Manifestations in HAV, HBV, and HCV Infections. In: Gershwin, M.E., Vierling, J.M., Manns, M.P. (eds) Liver Immunology. Humana Press. https://doi.org/10.1007/978-1-59745-518-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-518-3_17

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-818-8

  • Online ISBN: 978-1-59745-518-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics